Graphene-Based Platforms for Cancer Therapeutics

References

• Siegel R Ma J Zou Z Jemal A . Cancer statistics 2014. CA-Cancer J. Clin.64 (1), 9–29 (2014).
   PubMed Web of Science ®Google Scholar
• Torre LA Bray F Siegel RL Ferlay J Lortet-Tieulent J Jemal A . Global cancer statistics, 2012. CA-Cancer J. Clin.65 (2), 87–108 (2015).
   PubMed Web of Science ®Google Scholar
• Potash J Anderson KC . AACR Cancer Progress Report 2014: Transforming Lives Through Research. Clin. Cancer Res.20 (19), 4977 (2014).
   PubMed Web of Science ®Google Scholar
• Siegel R DeSantis C Virgo K et al. Cancer treatment and survivorship statistics, 2012. CA-Cancer J. Clin.62 (4), 220–241 (2012).
   PubMed Web of Science ®Google Scholar
• Sahni V Choudhury D Ahmed Z . Chemotherapy-associated renal dysfunction. Nat. Rev. Nephrol.5 (8), 450–462 (2009).
   PubMed Web of Science ®Google Scholar
• Alexis F Rhee J-W Richie JP Radovic-Moreno AF Langer R Farokhzad OC . New frontiers in nanotechnology for cancer treatment. Urol. Oncol. Semin. O I26 (1), 74–85 (2008).
   PubMed Web of Science ®Google Scholar
• Bharali DJ Mousa SA . Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol. Therapeut.128 (2), 324–335 (2010).
   PubMed Web of Science ®Google Scholar
• Haley B Frenkel E . Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. Semin. O I26 (1), 57–64 (2008).
   PubMed Web of Science ®Google Scholar
• Davis ME Shin DM . Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov.7 (9), 771–782 (2008).
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P Cook JM Florence AT . Nanosystem drug targeting: facing up to complex realities. J. Control. Release141 (3), 265–276 (2010).
   PubMed Web of Science ®Google Scholar
• Nichols JW Bae YH . Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today7 (6), 606–618 (2012).
   PubMed Web of Science ®Google Scholar
• Allen MJ Tung VC Kaner RB . Honeycomb carbon: a review of graphene. Chem. Rev.110, 132–145 (2010).
   PubMed Web of Science ®Google Scholar
• Geim AK Novoselov KS . The rise of graphene. Nat. Mater.6, 183–191 (2007).
   PubMed Web of Science ®Google Scholar
• Geim AK . Graphene: status and prospects. Science324, 1530–1534 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Y Li Z Wang J Lisend J Lin Y . Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol.29, 205–212 (2011).
   PubMed Web of Science ®Google Scholar
• Jokar S Pourjavadi A Adeli M . Albumin-graphene oxide conjugates; carriers for anticancer drugs. RSC Adv.4 (62), 33001–33006 (2014).
   Web of Science ®Google Scholar
• Segal M . Selling graphene by the ton. Nat. Nanotechnol.4, 612–614 (2009).
   PubMed Web of Science ®Google Scholar
• Talukdar Y Rashkow JT Lalwani G Kanakia S Sitharaman B . The effects of graphene nanostructures on mesenchymal stem cells. Biomaterials35 (18), 4863–4877 (2014).
   PubMed Web of Science ®Google Scholar
• Sun X Liu Z Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res.1 (3), 203–212 (2008).
   PubMed Web of Science ®Google Scholar
• Paratala BS Jacobson BD Kanakia S Francis LD Sitharaman B . Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons. PLoS ONE7 (6), e38185 (2012).
   PubMed Web of Science ®Google Scholar
• Tonelli FM Goulart VA Gomes KN et al. Graphene-based nanomaterials: biological and medical applications and toxicity. Nanomedicine10 (15), 2423–2450 (2015).
   PubMed Web of Science ®Google Scholar
• Yang Y Asiri AM Tang Z Du D Lin Y . Graphene based materials for biomedical applications. Mater. Today16 (10), 365–373 (2013).
   Web of Science ®Google Scholar
• Yang K Feng L Shi X Liu Z . Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev.42 (2), 530–547 (2013).
   PubMed Web of Science ®Google Scholar
• Shen H Zhang L Liu M Zhang Z . Biomedical applications of graphene. Theranostics2 (3), 283 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Y Nayak TR Hong H Cai W . Graphene: a versatile nanoplatform for biomedical applications. Nanoscale4 (13), 3833–3842 (2012).
   PubMed Web of Science ®Google Scholar
• Wang XM Zhang WH . Application of graphene derivatives in cancer therapy: a review. Carbon67, 795 (2014).
   Google Scholar
• Chung C Kim YK Shin D Ryoo SR Hong BH Min DH . Biomedical applications of graphene and graphene oxide. Accounts Chem. Res.46 (10), 2211–2224 (2013).
   PubMed Web of Science ®Google Scholar
• Bitounis D Ali‐Boucetta H Hong BH Min DH Kostarelos K . Prospects and challenges of graphene in biomedical applications. Adv. Mater.25 (16), 2258–2268 (2013).
   PubMed Web of Science ®Google Scholar
• Yang K Zhang S Zhang G Sun X Lee S-T Liu Z . Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett.10 (9), 3318–3323 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Z Robinson JT Sun X Dai H . PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc.130 (33), 10876–10877 (2008).
   PubMed Web of Science ®Google Scholar
• Yang X Zhang X Liu Z Ma Y Huang Y Chen Y . High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J. Phys. Chem. C112 (45), 17554–17558 (2008).
   Web of Science ®Google Scholar
• Zhang L Xia J Zhao Q Liu L Zhang Z . Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small6 (4), 537–544 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou T Zhou X Xing D . Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials35 (13), 4185–4194 (2014).
   PubMed Web of Science ®Google Scholar
• Wei G Dong R Wang D et al. Functional materials from the covalent modification of reduced graphene oxide and [small beta]-cyclodextrin as a drug delivery carrier. New J. Chem.38 (1), 140–145 (2014).
   Web of Science ®Google Scholar
• Xu Z Zhu S Wang M Li Y Shi P Huang X . Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. App. Mater. Interfaces7 (2), 1355–1363 (2015).
   PubMed Web of Science ®Google Scholar
• Angelopoulou A Voulgari E Diamanti EK Gournis D Avgoustakis K . Graphene oxide stabilized by PLA–PEG copolymers for the controlled delivery of paclitaxel. Eur. J. Pharm. Biopharm.93, 18–26 (2015).
   PubMed Web of Science ®Google Scholar
• Moore TL Podilakrishna R Rao A Alexis F . Systemic administration of polymer‐coated nano‐graphene to deliver drugs to glioblastoma. Part. Part. Syst. Char.31 (8), 886–894 (2014).
   Web of Science ®Google Scholar
• Qin XC Guo ZY Liu ZM Zhang W Wan MM Yang BW . Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. Photochem. Photobiol.120, 156–162 (2013).
   Web of Science ®Google Scholar
• Zhao X Liu P . Biocompatible graphene oxide as a folate receptor-targeting drug delivery system for the controlled release of anti-cancer drugs. RSC Adv.4 (46), 24232–24239 (2014).
   Web of Science ®Google Scholar
• Huang P Xu C Lin J et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics1, 240–250 (2011).
   PubMed Web of Science ®Google Scholar
• Lin Q Huang X Tang J Han Y Chen H . Environmentally friendly, one-pot synthesis of folic acid-decorated graphene oxide-based drug delivery system. J. Nanopart. Res.15 (12), 1–7 (2013).
   Web of Science ®Google Scholar
• Ross JF Chaudhuri PK Ratnam M . Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer73 (9), 2432–2443 (1994).
   PubMed Web of Science ®Google Scholar
• Yadav AK Mishra P Agrawal GP . An insight on hyaluronic acid in drug targeting and drug delivery. J. Drug Target.16 (2), 91–107 (2008).
   PubMed Web of Science ®Google Scholar
• Miao W Shim G Kang CM et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials34 (37), 9638–9647 (2013).
   PubMed Web of Science ®Google Scholar
• Wu H Shi H Wang Y et al. Hyaluronic acid conjugated graphene oxide for targeted drug delivery. Carbon69 (0), 379–389 (2014).
   Google Scholar
• Song E Han W Li C et al. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. App. Mater. Interfaces6 (15), 11882–11890 (2014).
   PubMed Web of Science ®Google Scholar
• Daniels TR Delgado T Rodriguez JA Helguera G Penichet ML . The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol.121 (2), 144–158 (2006).
   PubMed Web of Science ®Google Scholar
• Liu G Shen H Mao J et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. App. Mater. Interfaces5 (15), 6909–6914 (2013).
   PubMed Web of Science ®Google Scholar
• Liu G Shen H Mao J et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. App. Mater. Interfaces5 (15), 6909–6914 (2013).
   PubMed Web of Science ®Google Scholar
• Wang H Gu W Xiao N Ye L Xu Q . Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug. Int. J. Nanomed.9, 1433–1442 (2014).
   PubMed Web of Science ®Google Scholar
• Mullick Chowdhury S Lalwani G Zhang K Yang JY Neville K Sitharaman B . Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials34 (1), 283–293 (2013).
   PubMed Web of Science ®Google Scholar
• Mullick Chowdhury S Surhland C Sanchez Z et al. Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme. Nanomed. Nanotechnol.11 (1), 109–118 (2015).
   PubMed Web of Science ®Google Scholar
• Chowdhury SM Lalwani G Zhang K Yang JY Neville K Sitharaman B . Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials34 (1), 283–293 (2013).
   PubMed Web of Science ®Google Scholar
• Mullick Chowdhury S Manepalli P Sitharaman B . Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein. Acta Biomater.10 (10), 4494–4504 (2014).
   PubMed Web of Science ®Google Scholar
• Siddiqui S Fang M Ni B Lu D Martin B Maudsley S . Central role of the EGF receptor in neurometabolic aging. Int. J. Endocrinol.2012, 739428 (2012).
   PubMed Web of Science ®Google Scholar
• Ogino A Kitao H Hirano S et al. Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non–small cell lung cancer cell line. Cancer Res.67 (16), 7807–7814 (2007).
   PubMed Web of Science ®Google Scholar
• Lynch TJ Kim ES Eaby B Garey J West DP Lacouture ME . Epidermal growth factor receptor inhibitor–associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist12 (5), 610–621 (2007).
   PubMed Web of Science ®Google Scholar
• Luo M Kelley MR . Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res.24 (4), 2127–2134 (2004).
   PubMed Web of Science ®Google Scholar
• Sun X Liu Z Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res.1 (3), 203–212 (2008).
   PubMed Web of Science ®Google Scholar
• Wu AM Senter PD . Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol.23 (9), 1137–1146 (2005).
   PubMed Web of Science ®Google Scholar
• Yang X Zhang X Ma Y Huang Y Wang Y Chen Y . Superparamagnetic graphene oxide-Fe3O4 nanoparticles hybrid for controlled targeted drug carriers. J. Mater. Chem.19 (18), 2710–2714 (2009).
   Web of Science ®Google Scholar
• Yang X Wang Y Huang X et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J. Mater. Chem.21 (10), 3448–3454 (2011).
   Web of Science ®Google Scholar
• Sun X Liu Z Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res.1 (3), 203–212 (2008).
   PubMed Web of Science ®Google Scholar
• Felgner PL Gadek TR Holm M et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA84 (21), 7413–7417 (1987).
   PubMed Web of Science ®Google Scholar
• Notley SM Crawford RJ Ivanova EP . Bacterial interaction with graphene particles and surfaces. Nanotechnol. Nanomater.5, 99–118 (2013).
   Google Scholar
• Lv H Zhang S Wang B Cui S Yan J . Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release114 (1), 100–109 (2006).
   PubMed Web of Science ®Google Scholar
• Pérez-Martínez FC Guerra J Posadas I Ceña V . Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm. Res.28 (8), 1843–1858 (2011).
   PubMed Web of Science ®Google Scholar
• Li C Zhong D Zhang Y et al. The effect of the gene carrier material polyethyleneimine on the structure and function of human red blood cells in vitro. J. Mater. Chem. B1 (14), 1885–1893 (2013).
   PubMed Web of Science ®Google Scholar
• Feng L Zhang S Liu Z . Graphene based gene transfection. Nanoscale3 (3), 1252–1257 (2011).
   PubMed Web of Science ®Google Scholar
• Chen B Liu M Zhang L Huang J Yao J Zhang Z . Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem.21 (21), 7736–7741 (2011).
   Web of Science ®Google Scholar
• Kim H Namgung R Singha K Oh I-K Kim WJ . Graphene oxide–polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjugate Chem.22 (12), 2558–2567 (2011).
   PubMed Web of Science ®Google Scholar
• Feng L Yang X Shi X et al. Polyethylene glycol and polyethylenimine dual‐functionalized nano‐graphene oxide for photothermally enhanced gene delivery. Small9 (11), 1989–1997 (2013).
   PubMed Web of Science ®Google Scholar
• Ren T Li L Cai X Dong H Liu S Li Y . Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery. Polym. Chem.3 (9), 2561–2569 (2012).
   Web of Science ®Google Scholar
• Zhang L Lu Z Zhao Q Huang J Shen H Zhang Z . Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI‐grafted graphene oxide. Small7 (4), 460–464 (2011).
   PubMed Web of Science ®Google Scholar
• Zhi F Dong H Jia X et al. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS ONE8 (3), e60034 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang J Feng L Tan X et al. Dual‐polymer‐functionalized nanoscale graphene oxide as a highly effective gene transfection agent for insect cells with cell‐type‐dependent cellular uptake mechanisms. Part. Part. Syst. Char.30 (9), 794–803 (2013).
   Web of Science ®Google Scholar
• Zhou X Laroche F Lamers GE et al. Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos. Nano Res.5 (10), 703–709 (2012).
   Web of Science ®Google Scholar
• Yin D Li Y Lin H et al. Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo. Nanotechnologia24 (10), 105102 (2013).
   PubMed Web of Science ®Google Scholar
• Yang HW Huang CY Lin CW et al. Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging. Biomaterials35 (24), 6534–6542 (2014).
   PubMed Web of Science ®Google Scholar
• Lee ST Chu K Oh HJ et al. Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J. Neuro-Oncol.102 (1), 19–24 (2011).
   PubMed Web of Science ®Google Scholar
• Gollavelli G Ling YC . Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer cells. Biomaterials35 (15), 4499–4507 (2014).
   PubMed Web of Science ®Google Scholar
• Bonnett R . Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev.24 (1), 19–33 (1995).
   Web of Science ®Google Scholar
• Mensudar R . Photodynamic therapy-A review. World J. Med. Sci.10 (2), 139–142 (2014).
   Google Scholar
• Zhou L Wang W Tang J Zhou JH Jiang HJ Shen J . Graphene oxide noncovalent photosensitizer and its anticancer activity In vitro. Chem. Eur. J.17 (43), 12084–12091 (2011).
   PubMed Web of Science ®Google Scholar
• Wang S Gao R Zhou F Selke M . Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J. Mater. Chem.14 (4), 487–493 (2004).
   Web of Science ®Google Scholar
• Ravanat JL Douki T Cadet J . Direct and indirect effects of UV radiation on DNA and its components. Photochem. Photobiol.63 (1), 88–102 (2001).
   Web of Science ®Google Scholar
• Hu Z Li J Li C et al. Folic acid-conjugated graphene-ZnO nanohybrid for targeting photodynamic therapy under visible light irradiation. J. Mater. Chem.1 (38), 5003–5013 (2013).
   PubMed Web of Science ®Google Scholar
• Gilje S Dubin S Badakhshan A Farrar J Danczyk S Kaner RB . Photothermal deoxygenation of graphene oxide for patterning and distributed ignition applications. Adv. Mater.22 (3), 419–423 (2010).
   PubMed Web of Science ®Google Scholar
• Abdelsayed V Moussa S Hassan HM Aluri HS Collinson MM El-Shall MS . Photothermal deoxygenation of graphite oxide with laser excitation in solution and graphene-aided increase in water temperature. J. Phys. Chem. Lett.1 (19), 2804–2809 (2010).
   Web of Science ®Google Scholar
• Markovic ZM Harhaji-Trajkovic LM Todorovic-Markovic BM et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials32 (4), 1121–1129 (2011).
   PubMed Web of Science ®Google Scholar
• Robinson JT Tabakman SM Liang Y et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc.133 (17), 6825–6831 (2011).
   PubMed Web of Science ®Google Scholar
• Sasidharan A Sivaram AJ Retnakumari AP et al. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene. Adv. Health Mater.4 (5), 679–684 (2015).
   PubMed Web of Science ®Google Scholar
• Sherlock SP Tabakman SM Xie L Dai H . Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano5 (2), 1505–1512 (2011).
   PubMed Web of Science ®Google Scholar
• Miao W Shim G Lee S Lee S Choe YS Oh YK . Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials34 (13), 3402–3410 (2013).
   PubMed Web of Science ®Google Scholar
• Tian B Wang C Zhang S Feng L Liu Z . Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano5 (9), 7000–7009 (2011).
   PubMed Web of Science ®Google Scholar
• Sahu A Choi WI Lee JH Tae G . Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials34 (26), 6239–6248 (2013).
   PubMed Web of Science ®Google Scholar
• Park H Yang J Lee J Haam S Choi IH Yoo KH . Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano3 (10), 2919–2926 (2009).
   PubMed Web of Science ®Google Scholar
• Liu H Chen D Li L et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. Engl.123 (4), 921–925 (2011).
   Google Scholar
• Kim H Lee D Kim J Kim TI Kim WJ . Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano7 (8), 6735–6746 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang W Guo Z Huang D Liu Z Guo X Zhong H . Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials32 (33), 8555–8561 (2011).
   PubMed Web of Science ®Google Scholar
• Ma X Tao H Yang K et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res5 (3), 199–212 (2012).
   Web of Science ®Google Scholar
• Feng L Li K Shi X Gao M Liu J Liu Z . Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance. Adv. Health Mater.3 (8), 1261–1271 (2014).
   PubMed Web of Science ®Google Scholar
• Bian X Song ZL Qian Y et al. Fabrication of graphene-isolated-Au-nanocrystal nanostructures for multimodal cell imaging and photothermal-enhanced chemotherapy. Sci. Rep.4, 6093 (2014).
   PubMed Web of Science ®Google Scholar
• Qin XC Guo ZY Liu ZM Zhang W Wan MM Yang BW . Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. Photochem. Photobiol.120 (0), 156–162 (2013).
   Google Scholar
• Bao H Pan Y Ping Y et al. Chitosan‐functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small7 (11), 1569–1578 (2011).
   PubMed Web of Science ®Google Scholar
• Sheng Z Song L Zheng J et al. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials34 (21), 5236–5243 (2013).
   PubMed Web of Science ®Google Scholar
• Bianco A . Graphene: safe or toxic? The two faces of the medal. Angew. Chem. Int. Edit.52 (19), 4986–4997 (2013).
   PubMed Web of Science ®Google Scholar
• Seabra AB Paula AJ de Lima R Alves OL Duraán N . Nanotoxicity of graphene and graphene oxide. Chem. Res. Toxicol.27 (2), 159–168 (2014).
   PubMed Web of Science ®Google Scholar
• Jastrzębska AM Kurtycz P Olszyna AR . Recent advances in graphene family materials toxicity investigations. J. Nanopart. Res.14 (12), 1–21 (2012).
   PubMed Web of Science ®Google Scholar
• Ma Y Shen H Tu X Zhang Z . Assessing in vivo toxicity of graphene materials: current methods and future outlook. Nanomedicine9 (10), 1565–1580 (2014).
   PubMed Web of Science ®Google Scholar
• Feng L Liu Z . Graphene in biomedicine: opportunities and challenges. Nanomedicine6 (2), 317–324 (2011).
   PubMed Web of Science ®Google Scholar
• Zhou T Zhang B Wei P et al. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials35 (37), 9833–9843 (2014).
   PubMed Web of Science ®Google Scholar
• Zhou H Zhang B Zheng J et al. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration. Biomaterials35 (5), 1597–1607 (2014).
   PubMed Web of Science ®Google Scholar
• Jaworski S Sawosz E Grodzik M et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int. J. Nanomed.8, 413 (2013).
   PubMed Web of Science ®Google Scholar
• Yuan X Liu Z Guo Z Ji Y Jin M Wang X . Cellular distribution and cytotoxicity of graphene quantum dots with different functional groups. Nanoscale Res. Lett.9 (1), 1–9 (2014).
   PubMedGoogle Scholar
• Chng ELK Chua CK Pumera M . Graphene oxide nanoribbons exhibit significantly greater toxicity than graphene oxide nanoplatelets. Nanoscale6 (18), 10792–10797 (2014).
   PubMed Web of Science ®Google Scholar
• Mbeh DA Akhavan O Javanbakht T Mahmoudi M Yahia LH . Cytotoxicity of protein corona-graphene oxide nanoribbons on human epithelial cells. Appl. Surf. Sci.320, 596–601 (2014).
   Web of Science ®Google Scholar
• Mullick Chowdhury S Dasgupta S McElroy AE Sitharaman B . Structural disruption increases toxicity of graphene nanoribbons. J. App. Toxicol.34 (11), 1235–1246 (2014).
   PubMed Web of Science ®Google Scholar
• Yang K Wan J Zhang S Tian B Zhang Y Liu Z . The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials33 (7), 2206–2214 (2012).
   PubMed Web of Science ®Google Scholar
• Nurunnabi M Khatun Z Huh KM et al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano7 (8), 6858–6867 (2013).
   PubMed Web of Science ®Google Scholar
• Meyer JC Geim AK Katsnelson MI Novoselov KS Booth TJ Roth S . The structure of suspended graphene sheets. Nature446 (7131), 60–63 (2007).
   PubMed Web of Science ®Google Scholar
• Chen Y Guo F Jachak A et al. Aerosol synthesis of cargo-filled graphene nanosacks. Nano Lett.12 (4), 1996–2002 (2012).
   PubMed Web of Science ®Google Scholar
• Park SH Kim HK Yoon SB et al. Spray-assisted deep-frying process for the In situ spherical assembly of graphene for energy-storage devices. Chem. Mater.27 (2), 457–465 (2015).
   Web of Science ®Google Scholar
• Moore TL Pitzer JE Podila R et al. Multifunctional polymer-coated carbon nanotubes for safe drug delivery. Part. Part. Sys. Char.30 (4), 365–373 (2013).
   PubMed Web of Science ®Google Scholar
• Paratala B Hill L Mujica-Parodi L Caparelli E Wadghiri Y Sitharaman B . Graphene based MRI contrast agents: synthesis, characterization and in-vitro MRI. Proc. Int. Soc. Mag. Reson. Med.19, 1678 (2011).
   Google Scholar
• Lalwani G Sundararaj JL Schaefer K Button T Sitharaman B . Synthesis, characterization, in vitro phantom imaging, and cytotoxicity of a novel graphene-based multimodal magnetic resonance imaging-X-ray computed tomography contrast agent. J. Mater. Chem2 (22), 3519–3530 (2014).
   Web of Science ®Google Scholar
• Lalwani G Cai X Nie L Wang LV Sitharaman B . Graphene-based contrast agents for photoacoustic and thermoacoustic tomography. Photoacoustics1 (3–4), 62–67 (2013).
   PubMedGoogle Scholar
• Huang J Zong C Shen H Cao Y Ren B Zhang Z . Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy. Nanoscale5 (21), 10591–10598 (2013).
   PubMed Web of Science ®Google Scholar
• Podila R Brown JM . Toxicity of engineered nanomaterials: a physicochemical perspective. J. Biochem. Mol. Toxic27 (1), 50–55 (2013).
   PubMed Web of Science ®Google Scholar
• Wu C Wang C Han T Zhou X Guo S Zhang J . Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Adv. Health Mater.2 (12), 1613–1619 (2013).
   PubMed Web of Science ®Google Scholar
• Teo WZ Chng EL Sofer Z Pumera M . Cytotoxicity of halogenated graphenes. Nanoscale6 (2), 1173–1180 (2014).
   PubMed Web of Science ®Google Scholar
• Akhavan O Ghaderi E Emamy H Akhavan F . Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon54, 419–431 (2013).
   Web of Science ®Google Scholar
• Hashemi E Akhavan O Shamsara M Rahighi R Esfandiar A Tayefeh AR . Cyto and genotoxicities of graphene oxide and reduced graphene oxide sheets on spermatozoa. RSC Adv.4 (52), 27213–27223 (2014).
   Web of Science ®Google Scholar
• Kanakia S Toussaint JD Mullick Chowdhury S et al. Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials35 (25), 7022–7031 (2014).
   PubMed Web of Science ®Google Scholar